| 2-AG | 2-arachidonoylglycerol |
| 3-HA | 3-hydroxyanthranilic acid |
| 3-HK | 3-hydroxy-l-kynurenine |
| AEA | anandamide |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid |
| ANA | anthranilic acid |
| cAMP | cyclic adenosine monophosphate |
| CB1 | type 1 cannabinoid receptor |
| CB2 | type 2 cannabinoid receptor |
| CFA | complete Freund’s Adjuvant |
| CGRP | calcitonin gene-related peptide |
| CSD | cortical spreading depression |
| DRG | dorsal root ganglion |
| FAAH | fatty acid amide hydrolase |
| GABA | γ-Aminobutyric acid |
| GPCR | G-protein coupled receptor |
| GPR35 | G protein coupled receptor 35 |
| HINT1 | histidine triad nucleotide-binding protein 1 |
| IDO | indoleamine 2,3-dioxygenase |
| KA1 | N-(2-N,N-dimethylaminoethyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride |
| KA2 | N-(2-N-pyrrolidinylethyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride |
| KATII | kynurenine aminotransferase II |
| KMO | kynurenine 3-monooxygenase |
| KP | kynurenine pathway |
| KYNA | kynurenic acid |
| KYNU | l-kynurenine hydrolase |
| L-KYN | l-kynurenine |
| MAGL | monoacylglycerol lipase |
| MAP | mitogen-activated protein kinases |
| MOR | μ opioid receptor |
| NAD+ | nicotinamide adenine dinucleotid |
| NMDA | N-methyl-d-aspartate |
| NO | nitric oxide |
| NTG | nitroglycerin |
| NAc | nucleus accumbens |
| PAG | periaqueaductal grey |
| QUIN | quinolinic acid |
| TDO | tryptophan 2,3-dioxygenase |
| THC | Δ9-tetrahydrocannabinol |
| Trp | tryptophan |
| α7nAChR | α7 nicotinic acetylcholine receptor |
| σ1R | σ receptor type 1 |